Medicina Regenerativa y Bioingeniería de Tejidos

Responsable

• Marcela del Río (Catedrática de la Universidad Carlos III; CIEMAT).

Investigación

• Básica
• Clínica

Producción científica

Resumen 2017.

Publicaciones 2017.

Genetic diagnosis of epidermolysis bullosa: recommendations from an expert Spanish research group. Sánchez-Jimeno C, Escámez MJ, Ayuso C, Trujillo-Tiebas MJ, Del Río M, en representación de la Cátedra de la Fundación Jiménez Díaz de Medicina Regenerativa y Bioingeniería Tisular, DEBRA-España y de otros profesionales sanitarios..

Actas dermo-sifiliográficas. 2017 Nov 24.

PMID: 29180129

FI: 0

Early Exposure to a High Fat/High Sugar Diet Increases the Mammary Stem Cell Compartment and Mammary Tumor Risk in Female Mice.

Lambertz IU, Luo L, Berton TR, Schwartz SL, Hursting SD, Conti CJ, Fuchs-Young R.

Cancer prevention research. 2017 Oct;10(10):553-562.

PMID: 28904060

FI: 3,985

IKK?-Mediated Resistance to Skin Cancer Development Is <i>Ink4a/Arf-</i>Dependent.

Page A, Bravo A, Suarez-Cabrera C, Alameda JP, Casanova ML, Lorz C, Segrelles C, Segovia JC, Paramio JM, Navarro M, Ramirez A.

Molecular cancer research : MCR. 2017 Sep Volume: 15 Issue: 9 Pages: 1255-1264.

PMID: 28584022

FI: 4,974

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.

Hainzl S, Peking P, Kocher T, Murauer EM, Larcher F, Del Rio M, Duarte B, Steiner M, Klausegger A, Bauer JW, Reichelt J, Koller U.

Molecular therapy : the journal of the American Society of Gene Therapy. 2017 Nov 1;25(11):2573-2584.

PMID: 28800953

FI: 6,688

An RNA-targeted therapy for dystrophic epidermolysis bullosa.

Peking P, Koller U, Duarte B, Murillas R, Wolf S, Maetzig T, Rothe M, Kocher T, García M, Brachtl G, Schambach A, Larcher F, Reichelt J, Bauer JW, Murauer EM.

Nucleic acids research. Supplement. 2017 Sep 29 Volume: 45 Issue: 17 Pages: 10259-10269.

PMID: 28973459

FI: 10,162

Effects of photodynamic therapy on dermal fibroblasts from xeroderma pigmentosum and Gorlin-Goltz syndrome patients.

Zamarrón A, García M, Río MD, Larcher F, Juarranz Á.

Oncotarget 2017 Sep 29 Volume: 8 Issue: 44 Pages: 77385-77399.

PMID: 29100394

FI: 5,168

Liver Bioengineering Using Decellularized Whole-Liver Scaffolds.

Pla-Palacín I, Sainz-Arnal P, Morini S, Almeida M, Baptista PM.

Photosynthesis research protocols 2017 Nov 4.

PMID: 29101678

FI: 0

Classification of skin phenotypes caused by diabetes mellitus using complex scattering parameters in the millimeter-wave frequency range.

Dornuf F, Martín-Mateos P, Duarte B, Hils B, Bonilla-Manrique OE, Larcher F, Acedo P, Krozer V.

Scientific reports. 2017 Jul 19 Volume: 7 Issue: 1 Pages: 5822.

PMID: 28724970

FI: 4,259

Identical COL71A1 heterozygous mutations resulting in different dystrophic epidermolysis bullosa phenotypes.

Knöpfel N, Noguera-Morel L, Hernández-Martin A, García-Martin A, García M, Mencía Á, Pedrero RM, de Lucas R, Escámez MJ, Torrelo A.

Pediatric dermatology. 2017 Dec 22.

PMID: 29272047

FI: 0,990

Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatic analysis

Puig-Butille JA, Gimenez-Xavier P, Visconti A, Nsengimana J, Garcia-García F, Tell-Marti G, Escamez MJ, Newton-Bishop J, Bataille V, Del Río M, Dopazo J, Falchi M, Puig S.

Oncotarget 2017 Feb 14 Volume: 8 Issue: 7 Pages: 11589-11599.

PMID: 28030792

FI: 5,168

Reply

Luchetti MM, Moroncini G, Svegliati S, Larcher F, Avvedimento EV, Gabrielli A.

Arthritis & rheumatology 2017 Aug Volume: 69 Issue: 8 Pages: 1703-1704.

PMID: 28464528

FI: 6,918

Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes

Latella MC, Cocchiarella F, De Rosa L, Turchiano G, Gonçalves MAFV, Larcher F, De Luca M, Recchia A.

The Journal of investigative dermatology 2017 Apr Volume: 137 Issue: 4 Pages: 836-844.

PMID: 28027893

FI: 6,287

Foodomics evaluation of bioactive compounds in foods. Valdés A, Cifuentes A, León C.

Trends in Analytical Chemistry 2017 Nov;96:2-13

FI:8,442

Proyectos, Contratos y EOs vigentes 2017.

Fuentes de financiación públicas de proyectos que se están desarrollando en el IIS-FJD:

Imagen